We are live on ! Find out more
FQ

First Quadrant Portfolio holdings

AUM $18M
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.35%
10 Year Est. Return
–
AUM
$4.49B
AUM Growth
+$87.2M
Cap. Flow
-$70.7M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.9M
2
ELV icon
Elevance Health
ELV
+$26.5M
3
GILD icon
Gilead Sciences
GILD
+$20M
4
ZBRA icon
Zebra Technologies
ZBRA
+$18.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$18M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.8M
2
PKG icon
Packaging Corp of America
PKG
+$25.4M
3
AMGN icon
Amgen
AMGN
+$21.4M
4
HSY icon
Hershey
HSY
+$20.5M
5
EIX icon
Edison International
EIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Financials 16.33%
2 Technology 14.8%
3 Healthcare 13.84%
4 Industrials 13.25%
5 Energy 11.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PETM
201
DELISTED
PETSMART INC
PETM
$4.8M 0.11%
80,300
– –
TYL icon
202
Tyler Technologies
TYL
$13.7B
$4.79M 0.11%
52,500
– –
FDX icon
203
FedEx
FDX
$73B
$4.78M 0.11%
31,600
– –
WBA
204
DELISTED
Walgreens Boots Alliance
WBA
$4.74M 0.11%
63,900
+15,200
+31% +$1.06M
OCR
205
DELISTED
OMNICARE INC
OCR
$4.73M 0.11%
71,100
– –
AXE
206
DELISTED
Anixter International Inc
AXE
$4.71M 0.1%
47,101
– –
AON icon
207
Aon
AON
$80.6B
$4.7M 0.1%
52,200
– –
OA
208
DELISTED
Orbital ATK, Inc.
OA
$4.66M 0.1%
34,787
-96,852
-74% -$13.4M
OPLN
209
Openlane
OPLN
$4.28B
$4.62M 0.1%
383,354
+191,545
+100% +$2.21M
NUS icon
210
Nu Skin
NUS
$257M
$4.62M 0.1%
62,443
-87,100
-58% -$6.86M
LECO icon
211
Lincoln Electric
LECO
$14.1B
$4.54M 0.1%
64,900
-24,900
-28% -$1.69M
RGC
212
DELISTED
Regal Entertainment Group
RGC
$4.5M 0.1%
213,300
– –
CRL icon
213
Charles River Laboratories
CRL
$11.3B
$4.42M 0.1%
82,500
-73,900
-47% -$4.06M
SAFM
214
DELISTED
Sanderson Farms Inc
SAFM
$4.37M 0.1%
44,927
+36,227
+416% +$3.13M
PEP icon
215
PepsiCo
PEP
$196B
$4.35M 0.1%
48,700
+1,000
+2% +$86.4K
ANSS
216
DELISTED
Ansys
ANSS
$4.33M 0.1%
+57,100
New +$4.28M
WRB icon
217
W.R. Berkley
WRB
$28.1B
$4.31M 0.1%
314,381
– –
HST icon
218
Host Hotels & Resorts
HST
$17.5B
$4.28M 0.1%
194,300
+188,300
+3,138% +$4.05M
CXT icon
219
Crane NXT
CXT
$2.99B
$4.26M 0.09%
164,967
– –
TXN icon
220
Texas Instruments
TXN
$248B
$4.22M 0.09%
88,300
+75,100
+569% +$3.51M
BHE icon
221
Benchmark Electronics
BHE
$2.66B
$4.22M 0.09%
165,477
+33,877
+26% +$797K
SEIC icon
222
SEI Investments
SEIC
$12.3B
$4.2M 0.09%
128,000
– –
PNC icon
223
PNC Financial Services
PNC
$99.1B
$4.17M 0.09%
46,790
– –
SPXC icon
224
SPX Corp
SPXC
$9.39B
$4.1M 0.09%
+150,501
New +$3.91M
APA icon
225
APA Corp
APA
$13B
$4.1M 0.09%
40,737
-400
-1% -$36.2K
7 8
9
10 11

Similar funds

BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
SCM
SunTx Capital Management Dallas, Texas $21.3M AUM 12.38% 1-Year Est. Return
CFG
Claremont Financial Group Claremont, California $23.4M AUM
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
YEPV
Yorktown Energy Partners V New York $5.41M AUM
WIA
Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return
LSM
Light Sky Macro New York $1.34M AUM
FFIM
Founders Fund IV Management San Francisco, California $1.21M AUM

First Quadrant's Q2 2014 Portfolio in Review

As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
  • First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
  • First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
  • First Quadrant fully exited BALLY TECHNOLOGIES, INC. in Q2 2014, selling an estimated $14.7M.
  • First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
  • First Quadrant opened 109 new positions and closed 54 in Q2 2014.
  • First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.

Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.